Researchers are flocking to explore its potential, and naturally, one of the most pressing questions we receive at Real Peptides revolves around the tangible differences observed in 5-Amino-1MQ before and after its application
This is administered subcutaneously (under the skin) two to three times per week, and sometimes up to five days per week, for a course of about eight weeks 1 2
Mayer ML (2016) Structural biology of glutamate receptor ion channel complexes
doi: 10.1038/nature07201 217 RossolMHeineHMeuschUQuandtDKleinCSweetMJet al
The LEADER trial 28 (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results) studied a 1.8-mg dose in more than 9,000 patients with type 2 diabetes and found the incidence of acute pancreatitis was similar between the liraglutide and placebo groups (0.4% vs 0.5%, respectively)
Read the episode show notes at hubermanlab.com